ArticleBMC cancer2018

Genomics of NSCLC patients both affirm PD-L1 expression and predict their clinical responses to anti-PD-1 immunotherapy.

Kim A Brogden et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.